Regeneron agrees CRISPR/Cas licensing deal
14-04-2016
USPTO ignites CRISPR/Cas9 patent battle
13-01-2016
Are the Broad Institute’s CRISPR patents too broad?
29-10-2015
11-03-2016
Sararwut Jaimassiri / Shutterstock.com
The US Patent and Trademark Office (USPTO) has opened proceedings to determine who owns the rights to the CRISPR/Cas9 technology.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
News stories up to a week old and feature articles on the day of publication are accessible with a BASIC FREE ACCOUNT.
Register here for free content, or subscribe for access to archive.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’; and for basic access to the latest news on the website and weekly email news alerts choose the 'BASIC FREE ACCOUNT' registration.
CRISPR/Cas9, patent, US Patent and Trademark Office, USPTO, interference proceeding, Broad Institute, Harvard, University of California